顶部联系方式
HUAPONT PHARM
NEWS
Winning the bidding from centralised procurement
- Categories:2020
- Author:
- Origin:
- Time of issue:2020-09-22 08:38
- Views:0
【Summary】In order to cut drug prices low enough, China had been pushing forward a system that requires drug manufacturers to go through a bidding process and cut prices low enough if they want to sell their products at public hospitals via large-volume government procurement.
In the last 3 bidding processing, Chongqing Huapont pharm Co., Ltd.’s products: Moxifloxacin tablet, Anastrozole tablet and Levocetirizine HCL tablet were successful won in the centralised procurement process.
Centralised Procurement History:
1st Round: start from 2019 December 15th, total of 25 medicines were open for bidding, covering 11 provinces and regions；
2nd Round: start from 2020 January 17th, total of 33 medicines were open for bidding, covering 23 provinces and regions；
3rd Round: start from 2020 August 20th, total of 56 medicines were open for bidding, covering 25 provinces and regions；
Winning the bidding from centralised procurement
【Summary】In order to cut drug prices low enough, China had been pushing forward a system that requires drug manufacturers to go through a bidding process and cut prices low enough if they want to sell their products at public hospitals via large-volume government procurement.
In the last 3 bidding processing, Chongqing Huapont pharm Co., Ltd.’s products: Moxifloxacin tablet, Anastrozole tablet and Levocetirizine HCL tablet were successful won in the centralised procurement process.
Centralised Procurement History:
1st Round: start from 2019 December 15th, total of 25 medicines were open for bidding, covering 11 provinces and regions；
2nd Round: start from 2020 January 17th, total of 33 medicines were open for bidding, covering 23 provinces and regions；
3rd Round: start from 2020 August 20th, total of 56 medicines were open for bidding, covering 25 provinces and regions；
- Categories:2020
- Author:
- Origin:
- Time of issue:2020-09-22 08:38
- Views:0
In order to cut drug prices low enough, China had been pushing forward a system that requires drug manufacturers to go through a bidding process and cut prices low enough if they want to sell their products at public hospitals via large-volume government procurement.
In the last 3 bidding processing, Chongqing Huapont pharm Co., Ltd.’s products: Moxifloxacin tablet, Anastrozole tablet and Levocetirizine HCL tablet were successful won in the centralised procurement process.
Centralised Procurement History:
1st Round: start from 2019 December 15th, total of 25 medicines were open for bidding, covering 11 provinces and regions；
2nd Round: start from 2020 January 17th, total of 33 medicines were open for bidding, covering 23 provinces and regions；
3rd Round: start from 2020 August 20th, total of 56 medicines were open for bidding, covering 25 provinces and regions；
Scan the QR code to read on your phone
Share to
QUICK LINKS
Quick Links
Chongqing Guide: http://www.chongqing-guide.com
MEP: http://english.mep.gov.cn
CONTACT INFO
Contact Info
TEL: +86-23-67886927
TEL: +86-23-67886928
EMAIL: api@huapont.cn
ADD.: No.69 Xingguang Avenue, Renhe Town, Yubei District,Chongqing, China 401121
FEEDBACK
地址版权
© 2020 Chongqing Huapont Pharmaceutical Co., Ltd. All Rights Reserved. Powered by: www.300.cn 渝ICP备05003324号
手机版地址版权
© 2020 Chongqing Huapont Pharmaceutical Co., Ltd.